Kyle Gano
Fortune : 24 M $ au 31/05/2026
Fortune : 24 M $ au 31/05/2026
Kyle W.
Gano is currently President, Chief Executive Officer & Director at Neurocrine Biosciences, Inc. since 2024.
Dr. Gano is also a Director at Pharmaceutical Research & Manufacturers of America since 2024.
Education history includes an undergraduate degree from the University of Washington in 1996, an MBA and a doctorate from the University of California, Los Angeles, and an undergraduate degree from the University of Oregon.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 150 991 ( 0,15 % ) | 24 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Directeur Général | 11/10/2024 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | 01/10/2024 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national